Frédéric Robert appointed EUROAPI’s Chief Commercial Officer overseeing API Solutions and CDMO activities

Core Viewpoint - EUROAPI has appointed Frédéric Robert as Chief Commercial Officer to enhance its API Solutions and CDMO activities, aligning with its FOCUS-27 transformation plan [1][3]. Group 1: Appointment and Responsibilities - Frédéric Robert will oversee the creation of commercial synergies between API Solutions and CDMO operations, aiming to deliver the FOCUS-27 sales plan and redefine the global sales strategy [2][3]. - His role includes expanding the group's presence in strategic markets and optimizing customer approaches with integrated, high-value-added solutions [2]. Group 2: Frédéric Robert's Background - Frédéric Robert has over 25 years of experience in the pharmaceutical industry, previously serving as Vice President of Sales & Customs Development EMEA at Aptar [4]. - He has held senior leadership roles at NAOS Bioderma and Fareva, where he led global commercial operations and was part of the Executive Committee [4]. Group 3: Company Overview - EUROAPI is a leading player in active pharmaceutical ingredients, with approximately 200 products in its portfolio and strong R&D capabilities [5][6]. - The company operates six manufacturing sites in Europe and supplies customers in over 80 countries [6].